Determination of Risk Factors for Severe Life-Threatening Course of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children
暂无分享,去创建一个
V. Chasnyk | Y. Aleksandrovich | M. Kostik | A. Vilnits | E. Isupova | V. Masalova | K. Belozerov | I. Avrusin | O. Kalashnikova | N. Abramova | G. V. Kondratiev | O. S. Efremova | L. V. Bregel | T. Kornishina | Julia E. Konstantinova | Eugeniy Yu. Felker
[1] A. Randolph,et al. Variation in Early Anakinra Use and Short‐Term Outcomes in Multisystem Inflammatory Syndrome in Children , 2023, Arthritis & rheumatology.
[2] J. Książyk,et al. Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome , 2022, Frontiers in Pediatrics.
[3] O. Kalashnikova,et al. Heart Involvement in Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children: The Retrospective Multicenter Cohort Data , 2022, Frontiers in Pediatrics.
[4] G. Brisca,et al. Timely Recognition and Early Multi-Step Antinflammatory Therapy May Prevent ICU Admission of Patients With MIS-C: Proposal for a Severity Score , 2021, Frontiers in Pediatrics.
[5] O. Kalashnikova,et al. Distinguishing Between Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children and the Kawasaki Disease: Development of Preliminary Criteria Based on the Data of the Retrospective Multicenter Cohort Study , 2021, Frontiers in Pediatrics.
[6] I. Rabbone,et al. MIS-C Treatment: Is IVIG Always Necessary? , 2021, Frontiers in Pediatrics.
[7] S. Özen,et al. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study , 2021, Rheumatology International.
[8] R. Cron,et al. Performance of Cytokine Storm Syndrome Scoring Systems in Pediatric COVID‐19 and Multisystem Inflammatory Syndrome in Children , 2021, ACR open rheumatology.
[9] M. Oster,et al. Racial and Ethnic Disparities in Multisystem Inflammatory Syndrome in Children in the United States, March 2020 to February 2021 , 2021, The Pediatric infectious disease journal.
[10] Manish M Patel,et al. Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes , 2021, The New England journal of medicine.
[11] D. Walt,et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. , 2021, The Journal of clinical investigation.
[12] R. Sanders,et al. High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages , 2021, Science Translational Medicine.
[13] G. Zuccotti,et al. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey , 2021, Pediatric Rheumatology.
[14] M. Oster,et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study , 2021, The Lancet Child & Adolescent Health.
[15] Manish M Patel,et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. , 2021, JAMA.
[16] A. Belot,et al. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children. , 2021, JAMA.
[17] L. Henderson,et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2 , 2020, Arthritis & rheumatology.
[18] D. De Wolf,et al. Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe. , 2020, Circulation.
[19] A. García-Salido,et al. Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature , 2020, Journal of intensive care medicine.
[20] P. Zachariah,et al. Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019 in a Children's Hospital in New York City: Patient Characteristics and an Institutional Protocol for Evaluation, Management, and Follow-Up. , 2020, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[21] S. Tibby,et al. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process , 2020, The Lancet Child & Adolescent Health.
[22] K. Wilson,et al. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) , 2020, Cell.
[23] F. Haerynck,et al. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review , 2020, European Journal of Pediatrics.
[24] M. Malim,et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection , 2020, Nature Medicine.
[25] K. Reilly,et al. COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[26] J. Chou,et al. Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children. , 2020, The Journal of clinical investigation.
[27] P. Davies,et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study , 2020, The Lancet Child & Adolescent Health.
[28] David R. Holtgrave,et al. Multisystem Inflammatory Syndrome in Children in New York State , 2020, The New England journal of medicine.
[29] Michael Levin,et al. Childhood Multisystem Inflammatory Syndrome — A New Challenge in the Pandemic , 2020, The New England journal of medicine.
[30] Simon Li,et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.
[31] G. Carcelain,et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort , 2020, Annals of the Rheumatic Diseases.
[32] P. Davies,et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. , 2020, JAMA.
[33] Angelo Mazza,et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study , 2020, The Lancet.
[34] Naira M Mustafa,et al. Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis , 2020, Journal of Clinical Virology.
[35] F. Rovida,et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. , 2020, JAMA pediatrics.
[36] S. Maskatia,et al. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. , 2020, Hospital pediatrics.
[37] J. Ludvigsson. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults , 2020, Acta paediatrica.
[38] B. McCrindle,et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.
[39] C. Wouters,et al. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis , 2016, Annals of the rheumatic diseases.
[40] G. Hejblum,et al. Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome , 2014, Arthritis & rheumatology.
[41] M. Aricò,et al. HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis , 2007, Pediatric blood & cancer.
[42] A. Martini,et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. , 2005, The Journal of pediatrics.
[43] OUP accepted manuscript , 2021, Clinical Infectious Diseases.